Andrew Booth has served as AbCellera's Chief Financial Officer since August 2019 and previously served on the company's Board of Directors from June 2016 to August 2019, playing a key role in the company's 2020 Nasdaq IPO. Before AbCellera he spent roughly a decade at Vancouver-based STEMCELL Technologies Inc., serving as Chief Commercial Officer (2017-2019), Chief Financial Officer (2013-2017) and VP, Instrumentation (2010-2013). Earlier he spent seven years at GE, concluding as leader of M&A for GE Healthcare's EMEA and global Life Sciences businesses in London. He holds an MBA from INSEAD and a B.A.Sc. in Engineering Physics from the University of British Columbia.